Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2022-02-28 00:00:00 ET · period of report 2022-02-25 · accession 0001062993-22-005965 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-02-28 | 2022-02-25 | EWTX | ROOT JONATHAN D | Dir | J - Other | — | -3.47M | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-25 | J | D | 3,473,543 | — | 0 | I Directly owned by USVP XI | — | — | (F1) Represents a pro-rata, in-kind distribution by U.S. Venture Partners XI, L.P. without additional consideration to its partners. (F2) These securities are held of record by U.S. Venture Partners XI, L.P. (''USVP XI''). Presidio Management Group XI, L.L.C. ("PMG XI"), the general partner of USVP XI, has sole voting and dispositive power with respect to the shares held by USVP XI. The Reporting Person is a managing member of PMG XI with additional rights with respect to the issuer's securities, and may be deemed to have sole voting and dispositive power with respect to such shares. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein. |